Triveni Bio is a clinical-stage biotech company taking a genetics-informed approach and leveraging advanced antibody engineering to build first-in-class therapeutics that will redefine treatment paradigms for immune and inflammatory diseases.
See our pipeline
Our name reflects the confluence of our three foundational pillars: a genetics-informed approach, advanced antibody engineering and pioneering novel biology. Together, these shape our science and our culture.
Meet our team
Most approaches to treating atopic dermatitis focus on modulating inflammatory pathways, and in particular Th2 inflammation. Unfortunately, these approaches leave many patients behind. Triveni Bio is taking a novel approach intended for all atopic dermatitis patients by addressing the root cause of disease.
Read about it here